dc.relation.reference | Update: Severe acute respiratory syndrome--United States, 2003 (2003). MMWR Morb Mortal Wkly Rep. 52, 357-60.
Updated: outbreak of severe acute respiratory syndrome worldwide, 2003 (2003). MMWR Morb Mortal Wkly Rep. 52, 241-6.
Updated: outbreak of severe acute respiratory syndrome worldwide, 2003 (2003). MMWR Morb Mortal Wkly Rep. 52, 269-72.
Severe acute respiratory syndrome (SARS) and coronavirus testing, United States, 2003 (2003). MMWR, Morb Mortal Wkly Rep. 52, 297-302.
Global surveillance for severe acute respiratory syndrome (SARS) (2003). Wkly Epidemiol Rec. 78, 100-5.
World Health Organization. Acute respiratory syndrome (2003). Wkly Epidemiol Rec. 78, 73-4.
World Health Organization. Severe acute respiratory syndrome (SARS) (2003). Wkly Epidemiol Rec. 78, 81-3.
World Health Organization. Severe acute respiratory syndrome (SARS) mutil-country outbreak-update 15. http://www.who.int/csr/don/2003_03_31/en/.
World Health Organization. Severe acute respiratory syndrome (SARS) (2003). Wkly Epidemiol Rec. 78, 86.
Abbreviations for amino acids: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
Altschul, S.F. et al. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389.
Babcock, G.J., Esshaki, D.J., Tomas, W.D., Jr., and Ambrosino, D.M. (2004). Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J. Virol. 78, 4552-60.
Barry, M.A., Dower, W.J., and Johnson, S.A. (1996). Toward cell-targeting gene therapy vectors: Selection of cell-targeting peptides from random peptide-presenting
phage libraries. Nat. Med. 2, 299-305.
Bateman, A. et al. (2002). The Pfam Protein Families Database. Nucleic Acids Res. 30, 276.
Benitez, M.A. (2003). Hong Kong health chief falls ill with suspected SARS virus. Lancet 361, 1106.
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P.L., Murphy, B.R., Subbarao, K., and Moss, B. (2004). Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. USA 101, 6641-6.
Boivin, G., Abed, Y., Pelletier, G., Ruel, L., Moisan, D., Cote, S. et al. (2002). Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infectious in all age groups. J. Infect. Dis. 186, 1330-4.
Bonavia, A. et al. (2003). Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J. Virol. 77, 2530-8.
Bonnycastle, L.L.C., Mehroke, J.S., Rashed, M., Gong, X., and Scott, J.K. (1996). Probing the basis of antibody reactivity with a pane of constrained peptide libraries displayed by filamentous phage. J. Mol. Biol. 258, 747-62.
Bowditch, R.D., Tani, P., and McMillan, R. (1996). Characterization autoantigenic epitopes on platelet glycoprotein IIb/IIIa using random peptide libraries. Blood 88, 4579-84.
Brown, E.G., Liu, H., Kit, L.C., Baird, S., and Nesrallah, M. (2001). Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA 98, 6883-8.
Chan, K.H., Poon, L.L.M., Cheng, V.C.C. et al. Detection of SARS coronavirus (SARS-CoV) by RT-PCR, culture, and serology in patients with acute respiratory syndrome (SARS). Emerg. Infect. Dis. (in press).
Chan, P.K.S. et al. (2004). Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg. Infect. Dis. 9, 1058-63.
Chan, P.K.S., To, K.F., Wu, A., Tse, G.M.K., Chan, K.F., Lui, S.F., Sung, J.J.Y., Tam, J.S., and Tomlinson, B. (2004). Human metapneumovirus-associated atypical pneumonia and SARS. Emerg. Infect. Dis. 10, 497-500.
Chang, M.S. et al. (2004). Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochem. Biophysi. Res. Commun 314, 931-6.
Chen, L.L., Ou, H.Y., Zhang, R., and Zhang, C.T. (2003). ZCURVE_CoV: a new system to recoginze coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. Biochem. Biophys. Res. Commun. 307, 382-8.
Christian, M.D., Poutanen, S.M., Loutfy, M.R., Muller, M.P., and Low, D.E. (2004). Severe acute respiratory syndrome. CID 38, 1420-7.
Choy, W.Y., Lin, S.G., Chan, P.K.S. et al. (2004). Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development. Clin. Chem. 50, 1036-42.
Cortese, I., Tafi, R., Grimaldi, L.M.E. et al. (1996). Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. USA 93, 11063-7.
Dimitrov, D.S. (2004). The secret life of ACE2 as a receptor for the SARS virus. Cell, 652-653.
Ding, Y., Zhang, L.H., Huang, Z.H. et al. (2004). Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implication for pathogenesis and virus transmission pathways. J. Pathol. 203, 622-30.
Drazen, J.M. (2003). Case clusters of the severe acute respiratory syndrome. N. Engl. J. Med. 348, e6-7.
Drosten, C., Gunther, S., Preiser, W. et al. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967-76.
Drosten, C., Chiu, L.L., Panning, M. et al. (2004). Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J. Clin. Microbiol. 42, 2043-7.
Dybwad, A., Bogen, B., Batvig, J.B., Forre, O., and Sioud, M. (1995). Pepetide display libraries can be efficient tool for identifying antibody ligands for polyclonal antisera. Clin. Exp. Immunol. 102, 438-42.
Dybwad, A., Forre, O., Kjeldsen-Kragh, J., Natvig, J., and Sioud, M.B. (1993). Identification of new B cell epitopes in the sera rheumatoid arthritis patients using a random nanopeptide phage library. Eur. J. Immunol. 23, 3189-93.
Eliot, M., and Martin, E. (2004). Caution urged on SARS vaccines. Science 303, 944-6.
Ewald, P.W. (1998). The evolution of virulence and emerging diseases. J. Urban. Health 75, 480-91.
Falesey, A.R., Erdman, D., Anderson, L.J., Walsh, E.E. (2003). Human metapneumovirus infectious in young and elderly adults. J. Infect. Dis. 87, 785-90.
Fields, B.N., Knipe, D.M., Howley, P.M., and Grifn, D.E. Fields Virology (Lippincott Williams & Wilkins, Philadelphia, ed. 4, 2001).
Folgori, A., Tafi, R., Meola, A. et al. (1994). A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J. 13, 2236-43.
Fouchier, R.A.M., Kuiken, T., Schutten, M. et al. (2003). Koch’s postulates fulfilled for SARS virus. Nature 423, 240.
Freymuth, F., Vabret, A., Legrand, L., Eterradossi, N., Lafay-Delaire, F., Brouard, J. et al. (2003). Presence of the new human metapneumovirus in French children with bronchiolitis. Pedistr. Infect. Dis. J. 22, 92-4.
Gallagher, T.M, and Buchmeier, M.J. (2001). Coronavirus spike proteins in viral entry and pathogenesis. Virology 279, 371-4
Gao, W., Tamin, A., Soloff, A. et al. (2003). Effects of a SARS-associated coronavirus vaccine in monkeys. The Lancet 362, 1895-6.
Gerberding, J.L. (2003). Easter…but fast enough? Responding to the epidemic of severe acute respiratory syndrome. N. Engl. J. Med. 348, 2030-1.
Gevorkian, G., Manoutcharian, K., Almagro, J.C., Govezensky, T., and Dominguez, V. (1998). Identification of autoimmune thrombocytopnic purpura-related epitopes using phage-display peptide library. Clin. Immunol. Immunopathol. 86, 305-9.
Greenwood, J., Willis, A.E., and Perham, R.N. (1991). Multiple display of foreign peptides on a filamentous bacteriophage. J. Mol. Biol. 220, 821-7.
Hansen, M.H., Ostenstad, B., and Sioud, M. (2001). Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients. Mol. Med. 7, 230-9.
Henry, L.Y.C., Stephen, K.W.T., and Joseph, J.Y.S. (2003). Coronavirus in severe acute respiratory syndrome. TREBDS in Mol. Med. 9, 323-5.
Holmes, K.V., and Enjuanes, L. (2003). The SARS Coronavirus: A postgenomic era. Science 300, 1377-8.
Holmes, K.V. (1990). Coronaviridae and their replication. In Virology, 2nd edition, pp. 841-856. Edited by B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chancok, T. P. Monath, J. L. Melnick, B. Roizman and S. E. Straus. New York: Raven Press.
Holmes, K.V. (2003). SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Invest. 11, 1605-9.
Hsueh, P.R., Hsiao, C.H., Wang, W.K., Chen, P.J., Wang, J.T., Chang, S.C., Kao, C.L., and Yang, P.C. (2003). Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg. Infect. Dis. 9, 1163-7.
Hua, R., Zhou, Y., Wang, Y., Hua, Y., and Tong, G. (2004). Identification of two antigenic epitopes on SARS-CoV spike protein. Biochem. Biophys. Res. Commun. 319, 929-35.
Jartti, T., van den Hoogen, B., Garofalo, R.P., Osterhaus, A.D., Ruuskanen, O. (2002). Metapneumovirus and acute wheezing in children. Lancet 360, 1393-4.
Ksiazek, T.G. et al. (2003). A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1947-58. (a)
Ksiazek, T.G., Erdman, D., Goldsmith, C. et al. (2003). A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953-1966. (b)
Lee, N. et al. (2003). A major outbreak of severe acute repiratory syngrom in Hong Kong. N. Engl. J. Med. 348, 1986-94.
Li, G., Chen, X., and Xu, A. (2003). Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349, 508-99. (a)
Li, W., Moore, M.J., Vasilieva, N., Sui. J., Wong, S.K., Berne, M.A., Somasundaran, M., Sullivan, J.L., Luzuriaga, K., Greenough, T.C., Choe, H., and Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-5. (b)
Lin, Y., Shen, X., Yang, RU. et al. (2003). Identification of an epitope of SARS-coronavirus nucleocapsid protein. Cell Res.13, 141-5.
Luk, J., Gross, P., and Thompson, W.W. (2001). Obersrvations on mortality during the 1918 influenza pandemic. Clin. Infect. Dis. 33, 1375-8.
Manoutcharian, K., Sotelo, J., Garcia, E., Cano, A., and Gevorkian, G. (1999). Characterization of cerebrospinal fluid antibody specificities in neurocysticercosis using phage display peptide library. Clin. Immunol. 91, 117-21.
Marra, M.A., Jones, S.J., and Astell, C.R. et al. (2003). The genome sequence of the SARS-associated coronavirus. Science 300, 1399-404.
Mintz, P.J., Kim, J., Do, K., Wang, X., Zinner, R.G., Cristofanilli, M., Arap, M.A., Hong, W.K., Troncoso, P., Logothetis, C.J., Pasqualini, R., and Arap, W. (2002). Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat. Biotechnol. 21, 57-63.
Montagne, J.R.L., Simonsen, L., Taylor, R.J., and Turnbull, J. (2004). Severe acute respiratory syndrome: Developing a research response. J. Infect. Dis. 189, 634-41.
Ng, M.L., Tan, S.H., See, E.E., Ooi, E.E., and Ling, A.E. (2003). Proliferation growth od SARS coronavirus in Vero E6 cells. J. Gene. Virol. 84, 3291-303.
Nielsen, J.H., Engelbrecht, S., Brunak, G., and Heijne, V. (1997). Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10, 1.
Nissen, M.D., Mackay, I.M., Withers, S.J., Siebert, D.J., Sloots, T.P. (2002). Evidence of human metapneumovirus in Australian children. Med. J. 176, 188.
Osterhuas, A., and Fouchier, R. (2003). Human metapneumovirusin the community. Lancet 361, 890-1.
Oxford, J.S., Bossuyt, S., and Lambkin, R. (2003). A new infectious disease challenge: Urbani severe acute respiratory sndrome (SARS) associated coronavirus. Immunology 109, 326-8.
Pearson, H. (2004). Antibodies to SARS-like virus hint at repeated infections. Nature 427, 185.
Pearson, H., Clarke, T., Abbott, A., Knight, J., and Cyranoski, D. (2003). SARS: What have we learned? Nature 424, 121-6.
Pearson, W.R., and Lipman, D.J. (1988). Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. U.S.A. 85, 2444.
Peiris, J.S. et al. (2003). The severe acute respiratory syndrome. N. Engl. J. Med. 348, 2431-41.
Peiris, J.S.M., Lai, S.T., Poon, L.L.M. et al. (2003). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1312-3.
Peret, T.C., Boivin, G., Li, Y., Couillard, M., Humphrey, C., Osterhaus, A.D. et al. (2002). Characterization of human metapneumovirus isolated from patients in North America. J. Infect. Dis. 185, 1660-3.
Philips, J.J. et al. (2002). Murine coronavirus spike glycoprotein medicates degree of viral spread, inflammation and virus-induced immunopathology in the central nervous system. Virology 301, 109-20.
Poutanen, S.M., Low, D.E., Herny, B. et al.(2003). Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348, 1995-2005.
Prezzi, C., Nuzzo, M., Meola, A. et al. (1996). Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol 156, 4504-13.
Rivers, T.M.J. (1937). Bacteriol. 33, 1-12.
Rossa, W.K., Chiu, M.B., Stephen, S.C., Chim, Y.M., and Dennis, L. (2003). Molecular Epidemiology of SARS- From Amoy Gardens to Taiwan. N. Engl. J. Med. 349, 1875-6.
Rota, P.A. et al. (2003). Characterization of novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394-9.
Ruan, Y.J., Wei. C.L., Ee, A.L. et al. (2003). Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361, 1779-85.
Santamaria, H., Manoutcharian, K., Rocha, L., Gonzalez, E., Acero, G., Govezensky, T., Uribe, L.I., Olguin, A., Paniagua, J., and Gevorkian, G. (2001). Identification of peptide sequences specific for serum antibodies from Human Papillomavirus-infected patients using phage display libraries. Clin. Immunol. 101, 296-302.
Scott, J.K., and Smith, G.P. (1990). Searching for peptide ligands with an epitope library. Science 249, 386-90.
Shi, Y., Yi, Y., Li, P., Kuang, T., Li, L., Dong, M., Ma, Q., and Cao, C. (2003). Diagnosis of severe acute respiratory syndrome (SARS) by detction od SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J. Clin. Microbiol. 41, 5781-2.
Simmons, G., Reeves, J.D., Rennekamp, A.J., Amberg, S.M., Piefer, A.J., and Bates, P. (2004). Characterization of severe acute respiratory syndrom-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA 101, 4240-5.
Sioud, M., Dywad, A., Jespersen, L., Suleyman, S., Natvig, J.B., Sioud, M., and Forre, O. (1994). Characterization of naturally occurring autoantibodies against tumor necrosis factor-alpha (TNF-a) in vitro function and precise epitope mapping by phage epitope library. Clin. Exp. Immunol. 98, 520-5.
Sonnhammer, E.L., Heijne, G.V., and Krogh, A. (1998). Proc. Int. Conf. Intell. Syst. Mol. Biol. 6, 175.
Stephen, C.W., and Lane, D.P. (1992). Mutant conformation of p53 precise epitope mapping, a filamentous phage epitope library. J. Mol. Biol. 225, 577-83.
Stockton, J., Stephenson, I., Fleming, D., and Zambon, M. (2002). Human metapneumovirus as a cause of community-aquired respiratory illness. Emerg. Infect. Dis. 8, 897-901.
Sui, J. et al. (2004). Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci USA 101, 2536-41.
Tam, J.P. and Zavala, F. (1989). Multiple antigen peptide: a novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J Immunol Methods 124, 53-61.
Wang, J.Y., and Chang, S.C. (2004). Severe acute respiratory syndrome. Curr. Opin. in Infect. Dis. 17, 143-8.
Thiel, V., Ivanov, K.A., Putics, A. et al. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84, 2305-15.
Tsai, J.C. et al. (2003). The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J. Virol. 77, 841-50.
Tsang, K.W., Ho, P.L., Ooi, G.C. et al. (2003). A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1977-85.
Ware, L.B., and Matthay, M.A. (2000). The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334-49.
Willis, A.E., Perham, R.N., and Wraith, D. (1993). Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage. Gene 128, 79-83.
Wong, S.K., Li, W., Moore, M.J., Choe, H., and Farzan, M. (2004). A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279, 3197-201.
Woo, P.C.Y., Lau, S.K.P., Wong, B.H.L. et al. (2004). Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J. Clin. Microbiol. 42, 2306-9.
Wu, H.C., Huang, Y.L., Chao, T.T. et al (2001). Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. J. Clin. Microbiol. 39, 977-82. (a)
Wu, H.C., Yeh, C.T., Huang, Y.L., Tarn, L.J., and Lung, C.C. (2001). Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A. Appl. Environ. Microbiol. 67, 3201-7. (b)
Wu, H.C., Jung, M.Y., Chiu, C.Y., Chao, T.T., Lai, S.C., Jan, J.T., and Shaio, M.F. (2003). Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen. J. Gen. Virol. 84, 2771-9.
Yuen, K.Y., Chan, P.K., Periris, M., Tsang, D.N., Que, T.L., Shortridge, K.F., Cheung, P.T., To, W.K., Ho, E.T., Sung, R., and Cheng, A.F. (1998). Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351, 467-71.
van den Hoogen, B.G., de Jong, J.C., Kuiken, T., de Groot, R., Fouchier, R.A. et al. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7, 719-24.
Xiao, X., Chakraborti, S., Dimitrov, A.S., Gramatikoff, K., and Dimitrov, D.S. (2003). The SARS-CoV S glycoprotein: expression and funtional characterization. Biochem. Biophys. Res. Commun. 312, 1159-64.
Zhang, Y., Li, T., Fu, L. et al. (2004). Siliencing SARS-CoV spike protein expression in culture cells by RNA interference. FEBS 560, 141-6.
Ziebuhr, J., Snijder, E.J., and Gorbalenya, A.E. (2000). Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 81, 853. | en |